Back
Herbalife Ltd. 10K Form
Sell
46
HLF
Herbalife Ltd.
Last Price:
$12.08
Seasonality Move:
-2.35%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-01 | 10Q | HLF/Herbalife Ltd. Quarterly |
| 2023-08-02 | 10Q | HLF/Herbalife Ltd. Quarterly |
| 2023-05-02 | 10Q | HLF/Herbalife Ltd. Quarterly |
| 2022-10-31 | 10Q | HLF/Herbalife Ltd. Quarterly |
| 2022-08-02 | 10Q | HLF/Herbalife Ltd. Quarterly |
| 2022-05-03 | 10Q | HLF/Herbalife Ltd. Quarterly |
Receive HLF News And Ratings
See the #1 stock for the next 7 days that we like better than HLF
HLF Financial Statistics
Sales & Book Value
| Annual Sales: | $5B |
|---|---|
| Cash Flow: | $118M |
| Price / Cash Flow: | 5.73 |
| Annual Sales: | $-5.93 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 3.12990 |
|---|---|
| Net Income (TTM): | $320.6M |
| Gross Margin: | $3.8B |
| Return on Equity: | 0% |
| Return on Assets: | 11.88% |
Herbalife Ltd. Earnings Forecast
Key Herbalife Ltd. Financial Ratios
-
The Gross Profit Margin over the past 24 years for HLF is 75.84%.
-
The Selling, General & Administrative Expenses for HLF have been equal to 70.26% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 85.84% of Operating Income.
-
The Net Earning history of HLF is 5.09% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 15 years.
Herbalife Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Personal Care Products |
| Sector: | Consumer Staples |
| Current Symbol: | HLF |
| CUSIP: | G4412G |
| Website: | herbalife.com |
Debt
| Debt-to-Equity Ratio: | -3.62 |
|---|---|
| Current Ratio: | 1.11 |
| Quick Ratio: | 0.41 |
Price-to-Earnings
| Trailing P/E Ratio: | 4.83 |
|---|---|
| Forward P/E Ratio: | 4.39 |
HLF Technical Analysis vs Fundamental Analysis
Sell
46
Herbalife Ltd. (HLF)
is a Sell
Is Herbalife Ltd. a Buy or a Sell?
-
Herbalife Ltd. stock is rated a SellThe current Herbalife Ltd. [HLF] share price is $12.08. The Score for HLF is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.